157 related articles for article (PubMed ID: 28233873)
1. Computational methods using genome-wide association studies to predict radiotherapy complications and to identify correlative molecular processes.
Oh JH; Kerns S; Ostrer H; Powell SN; Rosenstein B; Deasy JO
Sci Rep; 2017 Feb; 7():43381. PubMed ID: 28233873
[TBL] [Abstract][Full Text] [Related]
2. Predicting the germline dependence of hematuria risk in prostate cancer radiotherapy patients.
Oh JH; Lee S; Thor M; Rosenstein BS; Tannenbaum A; Kerns S; Deasy JO
Radiother Oncol; 2023 Aug; 185():109723. PubMed ID: 37244355
[TBL] [Abstract][Full Text] [Related]
3. Machine Learning on a Genome-wide Association Study to Predict Late Genitourinary Toxicity After Prostate Radiation Therapy.
Lee S; Kerns S; Ostrer H; Rosenstein B; Deasy JO; Oh JH
Int J Radiat Oncol Biol Phys; 2018 May; 101(1):128-135. PubMed ID: 29502932
[TBL] [Abstract][Full Text] [Related]
4. Statistical-learning strategies generate only modestly performing predictive models for urinary symptoms following external beam radiotherapy of the prostate: A comparison of conventional and machine-learning methods.
Yahya N; Ebert MA; Bulsara M; House MJ; Kennedy A; Joseph DJ; Denham JW
Med Phys; 2016 May; 43(5):2040. PubMed ID: 27147316
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.
Kerns SL; Dorling L; Fachal L; Bentzen S; Pharoah PD; Barnes DR; Gómez-Caamaño A; Carballo AM; Dearnaley DP; Peleteiro P; Gulliford SL; Hall E; Michailidou K; Carracedo Á; Sia M; Stock R; Stone NN; Sydes MR; Tyrer JP; Ahmed S; Parliament M; Ostrer H; Rosenstein BS; Vega A; Burnet NG; Dunning AM; Barnett GC; West CM;
EBioMedicine; 2016 Aug; 10():150-63. PubMed ID: 27515689
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer.
Kerns SL; Stock RG; Stone NN; Blacksburg SR; Rath L; Vega A; Fachal L; Gómez-Caamaño A; De Ruysscher D; Lammering G; Parliament M; Blackshaw M; Sia M; Cesaretti J; Terk M; Hixson R; Rosenstein BS; Ostrer H
Radiother Oncol; 2013 Jun; 107(3):372-6. PubMed ID: 23719583
[TBL] [Abstract][Full Text] [Related]
7. A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer.
Kerns SL; Stock R; Stone N; Buckstein M; Shao Y; Campbell C; Rath L; De Ruysscher D; Lammering G; Hixson R; Cesaretti J; Terk M; Ostrer H; Rosenstein BS
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e21-8. PubMed ID: 23021708
[TBL] [Abstract][Full Text] [Related]
8. Validation of genetic predictors of late radiation-induced morbidity in prostate cancer patients.
Schack LMH; Petersen SE; Nielsen S; Lundby L; Høyer M; Bentzen L; Overgaard J; Andreassen CN; Alsner J
Acta Oncol; 2017 Nov; 56(11):1514-1521. PubMed ID: 28844157
[TBL] [Abstract][Full Text] [Related]
9. TGFB1 single nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapy.
Peters CA; Stock RG; Cesaretti JA; Atencio DP; Peters S; Burri RJ; Stone NN; Ostrer H; Rosenstein BS
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):752-9. PubMed ID: 17689884
[TBL] [Abstract][Full Text] [Related]
10. Contrasting analytical and data-driven frameworks for radiogenomic modeling of normal tissue toxicities in prostate cancer.
Coates J; Jeyaseelan AK; Ybarra N; David M; Faria S; Souhami L; Cury F; Duclos M; El Naqa I
Radiother Oncol; 2015 Apr; 115(1):107-13. PubMed ID: 25818395
[TBL] [Abstract][Full Text] [Related]
11. Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancer.
Burri RJ; Stock RG; Cesaretti JA; Atencio DP; Peters S; Peters CA; Fan G; Stone NN; Ostrer H; Rosenstein BS
Radiat Res; 2008 Jul; 170(1):49-59. PubMed ID: 18582155
[TBL] [Abstract][Full Text] [Related]
12. [Dosimetric factors predictive of late toxicity in prostate cancer radiotherapy].
de Crevoisier R; Fiorino C; Dubray B
Cancer Radiother; 2010 Oct; 14(6-7):460-8. PubMed ID: 20797890
[TBL] [Abstract][Full Text] [Related]
13. Identifying novel biomarkers of gastric cancer through integration analysis of single nucleotide polymorphisms and gene expression profile.
Wang T; Xu Y; Hou P
Int J Biol Markers; 2015 Jul; 30(3):e321-6. PubMed ID: 25982683
[TBL] [Abstract][Full Text] [Related]
14. A new efficient method to detect genetic interactions for lung cancer GWAS.
Luyapan J; Ji X; Li S; Xiao X; Zhu D; Duell EJ; Christiani DC; Schabath MB; Arnold SM; Zienolddiny S; Brunnström H; Melander O; Thornquist MD; MacKenzie TA; Amos CI; Gui J
BMC Med Genomics; 2020 Oct; 13(1):162. PubMed ID: 33126877
[TBL] [Abstract][Full Text] [Related]
15. Random forests to predict rectal toxicity following prostate cancer radiation therapy.
Ospina JD; Zhu J; Chira C; Bossi A; Delobel JB; Beckendorf V; Dubray B; Lagrange JL; Correa JC; Simon A; Acosta O; de Crevoisier R
Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1024-1031. PubMed ID: 25035205
[TBL] [Abstract][Full Text] [Related]
16. Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancer.
Damaraju S; Murray D; Dufour J; Carandang D; Myrehaug S; Fallone G; Field C; Greiner R; Hanson J; Cass CE; Parliament M
Clin Cancer Res; 2006 Apr; 12(8):2545-54. PubMed ID: 16638864
[TBL] [Abstract][Full Text] [Related]
17. Use of a Novel Nonparametric Version of DEPTH to Identify Genomic Regions Associated with Prostate Cancer Risk.
MacInnis RJ; Schmidt DF; Makalic E; Severi G; FitzGerald LM; Reumann M; Kapuscinski MK; Kowalczyk A; Zhou Z; Goudey B; Qian G; Bui QM; Park DJ; Freeman A; Southey MC; Al Olama AA; Kote-Jarai Z; Eeles RA; Hopper JL; Giles GG;
Cancer Epidemiol Biomarkers Prev; 2016 Dec; 25(12):1619-1624. PubMed ID: 27539266
[TBL] [Abstract][Full Text] [Related]
18. Erectile function after stereotactic body radiotherapy for localized prostate cancer.
Dess RT; Hartman HE; Aghdam N; Jackson WC; Soni PD; Abugharib AE; Suy S; Desai NB; Zumsteg ZS; Mehra R; Morgan TM; Feng FY; Hamstra DA; Schipper MJ; Collins SP; Spratt DE
BJU Int; 2018 Jan; 121(1):61-68. PubMed ID: 28710895
[TBL] [Abstract][Full Text] [Related]
19. TGFB1 single-nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapy. In regard to Peters et al. (Int J Radiat Oncol Biol Phys 2008;70:752-759).
Langsenlehner T; Kapp KS; Langsenlehner U
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):960; author reply 960-1. PubMed ID: 18514790
[No Abstract] [Full Text] [Related]
20. Association between single nucleotide polymorphisms in the gene for XRCC1 and radiation-induced late toxicity in prostate cancer patients.
Langsenlehner T; Renner W; Gerger A; Hofmann G; Thurner EM; Kapp KS; Langsenlehner U
Radiother Oncol; 2011 Mar; 98(3):387-93. PubMed ID: 21345510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
